These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 3151334)
1. Antibacterial activity of ciprofloxacin against immobilized Pseudomonas aeruginosa. Konrad-Dalhoff I; Dalhoff A Chemioterapia; 1987 Jun; 6(2 Suppl):137-8. PubMed ID: 3151334 [No Abstract] [Full Text] [Related]
2. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa. Solak S; Willke A; Ergönül O; Tekeli E Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492 [No Abstract] [Full Text] [Related]
3. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media. Jang CH; Park SY Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816 [TBL] [Abstract][Full Text] [Related]
4. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa. Parte AC; Smith JT Microbios; 1994; 80(322):31-9. PubMed ID: 7854197 [TBL] [Abstract][Full Text] [Related]
5. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa. Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863 [No Abstract] [Full Text] [Related]
6. Activity of 4-quinolones against Pseudomonas aeruginosa. Morissey I; Smith JT Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity testing of Pseudomonas aeruginosa to ciprofloxacin: comparison of the modified Stokes' method with MIC results obtained by the Etest. Galloway A; Wright J; Murphy O; Dickinson G J Antimicrob Chemother; 1999 Feb; 43(2):314-5. PubMed ID: 11252344 [No Abstract] [Full Text] [Related]
8. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin]. Hu AX; Wang YT; You TB Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234 [TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model. Zelenitsky SA; Iacovides H; Harding GK; Ariano RE Diagn Microbiol Infect Dis; 2004 May; 49(1):67-70. PubMed ID: 15135504 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial effect of octylcyanoacrylate against ciprofloxacin-resistant Pseudomonas aeruginosa isolates from patients with chronic suppurative otitis media. Jang CH; Park H; Cho YB; Choi CH; Song C In Vivo; 2009; 23(1):183-5. PubMed ID: 19368147 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro. Kobayashi Y; Sumitani Y; Sugita K; Aikawa N Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870 [No Abstract] [Full Text] [Related]
12. Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime. Alyaseen SA; Piper KE; Rouse MS; Steckelberg JM; Patel R Antimicrob Agents Chemother; 2005 Jun; 49(6):2543-5. PubMed ID: 15917569 [TBL] [Abstract][Full Text] [Related]
13. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128 [TBL] [Abstract][Full Text] [Related]
14. In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin. Cai Y; Wang R; An MM; Liang BB; Fang Y Int J Antimicrob Agents; 2008 Feb; 31(2):179-80. PubMed ID: 18083012 [No Abstract] [Full Text] [Related]